Author:
Alshibani Nouf,AlKattan Reem,Allam Eman,Alshehri Fahad A.,Shalabi Manal Matouq,Almuhanna Nada,Almarshad Houriah,Aljamili Anfal
Abstract
Abstract
Objective
To investigate the effects of metformin (MF) treatment on the matrix metalloproteinases (MMPs) and proinflammatory cytokines production from lipopolysaccharide (LPS) - stimulated human gingival fibroblasts (HGFs).
Methods
HGFs were obtained from subcultures of biopsies from clinically healthy gingival tissues of patients undergoing oral surgeries. Cell cytotoxicity assay was used to determine the effect of different concentrations of MF on viability of HGFs. HGFs were then incubated and treated with different concentrations of MF and Porphyromonas gingivais (Pg) LPS. MMP-1, MMP-2, MMP-8, MMP-9, IL-1β, and IL-8 expression analysis was performed using xMAP technology (Luminex 200, Luminex, Austin, TX, USA). Student’s t-test for a single sample was used to compare the mean values of the study groups with the control value. A p-value of <0.05 and 95% confidence intervals were used to report the statistical significance and precision of mean values.
Results
Concentrations of 0.5, 1- and 2-mM MF had a minimal non-significant cytotoxic effect on the HGFs and caused statistically significant reduction of MMP-1, MMP-2, MMP-8 and IL-8 expressed by the LPS-stimulated HGFs.
Conclusion
The results of the present study confirm that MF suppresses MMP-1, MMP-2, MMP-8 and IL-8 in LPS-stimulated HGFs suggesting an anti-inflammatory effect of MF and potential adjunct therapeutic role in the treatment of periodontal diseases.
Funder
the College of Dentistry Research Centre (CDRC) and the Deanship of Scientific Research at King Saud University
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Pihlstrom B, Michalowicz B, Johnson N. Periodontal diseases. Lancet. 2005;19 366(9499):1809–20.
2. Di Benedetto A, Gigante I, Colucci S, Grano M. Periodontal Disease: linking the primary inflammation to bone loss. Clin Dev Immunol. 2013;2013:1–7.
3. Liu J, Zhao J, Li C, Yu N, Zhang D, Pan Y. Clinical and microbiologic effect of nonsurgical periodontal therapy on patients with chronic or aggressive periodontitis. Quintessence Int. 2013;44:575–83.
4. Emani S, Gunjiganur G, Mehta D. Determination of the antibacterial activity of simvastatin against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans: an in vitro study. Contep Clin Dent. 2014;5(3):377–82.
5. Buduneli N, Kinane D. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J Clin Periodontol. 2011;38,:85–105.